• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA raises user fees

FDA raises user fees

September 10, 2010 By MassDevice staff

FDA logo

The Food & Drug Administration boosted the user fees medical device makers pay for applications for clearance or approval from the federal watchdogs.

The new fee schedule for fiscal year 2011, which goes into effect Oct. 1, institutes across-the-board hikes of 8.5 percent. Companies must pay an initial fee of $2,179 to register with the FDA.

The agency first announced its plans for the fee hike in April. Medical device companies, whose user fees have funded an increasing share of Food & Drug Administration’s device review budget, will have a chance to weigh in on how well the program is working at a Sept. 14 public workshop. The federal watchdog agency will offer its own views and solicit input from consumers, patients, healthcare professionals, scientific and academic experts at the meeting, which is scheduled a full two years ahead of the September 2012 expiration date for the current medical device user fee program.

Before FDA started collecting user fees for devices in fiscal 2003, the agency’s medical device program “suffered a long-term, significant loss of resources that undermined the program’s capacity and performance,” according to the announcement of the upcoming workshop.

The agency first won the authority to collect user fees under the 2002 Medical Device User Fee and Modernization Act. The program was reauthorized in 2007 under MDUFMA II. The user fees were supposed to make up for the FDA’s resource shortfall to help it review device applications more quickly and, ultimately, speed devices to market. In return for receiving industry funding, the FDA was tasked with meeting performance goals under MDUFMA, which set benchmarks for measuring improvements in the agency’s review times.

But the agency itself acknowledges that its record in meeting those goals has been “mixed," according to an April 20 performance report, which said it’s "unlikely" that the FDA will meet some of the goals for the PMA protocol.

Here’s how the new fees break down, comparing FY2010 rates with the upcoming fiscal year’s rates:

510(k) and 513(g) User Fees
Submission 2010 Standard Fee 2011 Standard Fee % Increase
510(k) $4,007 $4,348 8.5%
513(g) $2,941 $3,191 8.5%
Small Business User Fees
Submission 2010 Fee 2011 Fee % Increase
510(k) $2,004 $2,174 8.5%
513(g) $1,470 $1,595 8.5%

 

PMA User Fees
Submission 2010 Standard Fee 2011 Standard Fee % Increase
Premarket Application $217,787 $236,298 8.5%
First application* n/a waived
Panel-track Supplement $163,340 $177,224 8.5%
Efficacy Supplement (for BLA) $217,787 $236,298 8.5%
180-day Supplement $32,668 $35,445 8.5%
Real-time Supplement $15,245 $16,541 8.5%
Annual Report $7,623 $8,270 8.5%
30-day Notice $3,485 $3,781 8.5%
Small Business Fees
Submission 2010 Fee 2011 Fee % Increase
Premarket Application $54,447 $59,075 8.5%
First application* n/a waived
Panel-track Supplement $40,835 $44,306 8.5%
Efficacy Supplement (for BLA) $54,447 $59,075 8.5%
180-day Supplement $8,167 $8,861 8.5%
Real-time Supplement $3,811 $4,135 8.5%
Annual Report $1,906 $2,068 8.5%
30-day Notice $1,742 $1,890 8.5%

* For firms with firms with gross receipts or sales ≤ $30 million

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: Gift Bans

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy